Nimotuzumab, a humanized antibody targeting epidermal growth factor receptor, has potent
anti-proliferative, anti-angiogenic, and pro-apoptotic effects in vitro and in vivo. It also …

Dental care costs in the United States exceed $100 billion annually. Personalized medicine
efforts in dentistry are driven by potentially compelling clinical utility and cost‐effectiveness …

Osteopontin (OPN) is a phosphoprotein that activates several aspects of tumor progression.
Alternative splicing of the OPN primary transcript generates three splicing isoforms, OPNa …

We previously reported that the EGFR-targeted inhibitor erlotinib induces G1 arrest of
squamous cell carcinoma of the head and neck (SCCHN) cell lines without inducing …

Enthusiasm for the use of dietary bioactive compounds as chemopreventive agents and
adjuvants for current therapies has increased laboratory research conducted on several …

Despite the low incidence, squamous cell carcinoma (SCC) remains the most common
scrotal malignancy with a propensity for recurrence and metastasis. In recent years there …

Background: Combined chemoradiation therapy is the gold standard in the treatment of
squamous cell anal cancer (SCAC). However, even if the response rate is very high, many …

Importance ThePIK3CAmutation is one of the most common mutations in head and neck
squamous cell carcinoma (HNSCC). Through this research we attempt to elicit the role of …

Radiation therapy is the primary treatment in nasopharyngeal carcinoma (NPC), and the
effect of radiation therapy is strongly related to the oxygen content of cancer cells. That …

Squamous cell carcinomas (SCC) are the most common malignant tumors that arise in the
head and neck. Despite advances in the management of affected patients, the mortality …